about
Systematic review of data concerning etiopathology of ovarian hyperstimulation syndrome.Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.EMAS position statement: Managing the menopause in women with a past history of endometriosis.Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS).EMAS position statement: Vitamin D and postmenopausal health.Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium.A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients.Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study.Influence of HRT on prognostic factors for breast cancer: a systematic review after the Women's Health Initiative trial.Policy of IVF centres towards oocytes affected by Smooth Endoplasmic Reticulum aggregates: a multicentre survey study.Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club.Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club.Effects of Dairy Products Consumption on Health: Benefits and Beliefs--A Commentary from the Belgian Bone Club and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases.Management of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006.Improving quality of life after breast cancer: prevention of other diseases.Health technology assessment in osteoporosis.Vitrification of blastocysts derived from fair to poor quality cleavage stage embryos can produce high pregnancy rates after warming.Breast cancer seeding associated with core needle biopsies: a systematic review.EMAS position statement: managing the menopause in women with epilepsy.EMAS position statement: managing obese postmenopausal women.EMAS position statement: Managing women with premature ovarian failure.EMAS position statement: Bone densitometry screening for osteoporosis.EMAS position statement: Managing the menopause in the context of coronary heart disease.EMAS position statement: Managing menopausal women with a personal or family history of VTE.EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis.Postmenopausal hormone therapy: risks and benefits.Can healthy babies originate from oocytes with smooth endoplasmic reticulum aggregates? A systematic mini-review.Skeletal health in breast cancer survivors.The use of selective progestin receptor modulators (SPRMs) and more specifically ulipristal acetate in the practice of gynaecology.In vitro fertilization when men, women, or both partners are positive for HIV: a case-control study.Maternal thyroid parameters in pregnant women with different ethnic backgrounds: Do ethnicity-specific reference ranges improve the diagnosis of subclinical hypothyroidism?Oocytes affected by smooth endoplasmic reticulum aggregates: to discard or not to discard?In vitro fertilization for women infected by hepatitis C virus: a matched case-control study and a systematic literature review.Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.Climacteric medicine: European Menopause and Andropause Society (EMAS) statements on postmenopausal hormonal therapy.Prevalence of thyroid autoimmunity and dysfunction in women with iron deficiency during early pregnancy: is it altered?Optimal management of HIV-infected women during pregnancy and delivery: an audit of compliance with recommendations.Menopausal hormone therapy use in relation to breast cancer incidence in 11 European countries.What information do public organizations provide to Belgian women on primary prevention of breast cancer?Domestic violence during pregnancy: survey of patients and healthcare providers.
P50
Q30752882-73B09CA5-D16D-4EBC-BDEF-32D0BF0F32DEQ30877789-88B80F0D-2051-4628-A599-9BA5832649F0Q34125811-B35441BE-EBAB-46B4-AA3A-8EE96E8DA763Q34183801-CEF97DAA-3F77-45AE-AC30-18F481044F9FQ34234242-8136443B-812B-4C59-9F33-D26E2942AAD7Q34277111-54CE2A2E-A61E-4A8F-B322-A5D301AB9015Q34700608-F21D44BC-E689-4B6B-90D3-6B9ACCE597CDQ35571638-BC190F19-C2D8-4CC5-9F7B-FDCD176F6642Q35681592-B0FA9161-B5C1-4F94-B05A-E733CE228668Q35816214-5117B34A-B0E6-4998-B2DE-EC4DBEE7D53EQ36052183-E5C9615A-0278-498D-B266-1954C8CFD33FQ36283113-D34AE84C-1306-4BB3-9D0A-AF00F99E3449Q36437407-5AFF1850-8DB7-46F2-9F79-34F9C5355977Q36649227-D26B4E4A-2BC1-47EC-B861-D48F8D372348Q36836129-447BF5AF-A728-4A1E-AE6C-6ABA5FAC36A8Q36965411-D48C77DA-0534-424D-831E-BC18E286663BQ37214097-839AB447-53B3-4553-BED3-6A83BBA7EE87Q37376622-39E02399-556D-45D2-8050-CE7FEC0DCAFDQ37736887-540630EA-05C4-43D3-80E5-85080A035469Q37740547-CE3A09D9-23AE-4A25-9DE2-FC102321681FQ37770300-464334E5-00CD-4B45-A25C-ABF094C34FB8Q37811168-7FB583CF-C7ED-4D32-8279-1257D93B9F2BQ37820749-2C2FF5B7-B56F-483B-A583-D0810CAFD95EQ37864789-1DFBB428-C978-41CB-8BDF-08C58B532951Q37969271-7063C1DF-CE60-41BC-8660-1968961E791EQ38082563-3C90D759-E25A-433B-8D9A-5340E6C29F63Q38210527-D01D1617-FC6B-4431-9844-44BAC0E1D159Q38609579-FE31B0F6-AF90-4FEC-9B7E-C962A83029FDQ38676367-9A4A9F61-EBA7-4220-9A02-5E1E6FC3ABC2Q38819109-57D36460-B5D1-4931-AE28-BC2C67B8C0D1Q38873684-13825C98-0AC6-40F5-95F7-E7225EAB5A2CQ38894350-15A80148-B2AF-4DA5-A2A4-154625096530Q38943009-696A9DDE-E948-43D2-9DC6-3D30611D9651Q39367275-ABE083E9-76CE-4F6F-8B78-821DA72FB2CDQ39379063-F4B6496B-14A6-4E56-9876-74975FA60193Q39567239-BCCE4C2B-9B1C-4A47-97C2-B478E16ED61BQ39924088-986A415E-6EDF-44C4-AAAA-8F6AE467493DQ40225497-8129C9B3-3682-4973-9B9A-F82133689B75Q43231636-725A7C66-11FF-48A1-A360-471558B7F634Q43840492-6713E0C8-7EE1-4677-A6CC-FF0FFA9C0CDD
P50
name
Serge Rozenberg
@en
type
label
Serge Rozenberg
@en
prefLabel
Serge Rozenberg
@en